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We investigated peroxisomal alterations in mice treated with different
doses of Lorenzo’s Oil (a therapy for X-linked adrenoleukodystrophy
patients) for up to 100 days. Hepatic erucic acid levels were already
significantly increased 2.2-fold and 2.6-fold in mice treated with 10%
and 20% Lorenzo’s Oil for 21 days, respectively. No lipidosis was
found in liver, myocardium and kidney of any of the treated mice.
While hepatic catalase, lauroyl-CoA oxidase and glycolate oxidase,
and renal catalase activities were not induced by either diet, myocar-
dial catalase activity was increased in most groups. This suggests that
the mechanism of the effect of Lorenzo’s Oil in X-linked adrenoleu-
kodystrophy patients may not be a direct effect on the peroxisomes.
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Introduction
Lorenzo’s Oil, a 4:1 mixture of glycerol trioleate and glycerol trierucate is
prescribed as a diet supplement to patients with X-linked adrenoleu-
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kodystrophy. These patients suffer from progressive demyelination of the
central nervous system, adrenal insufficiency, and accumulation of very-
long-chain fatty acids. Peroxisomal b-oxidation of very-long-chain fatty
acids is deficient. X-linked adrenoleukodystrophy is caused by a defect of
a gene coding for an ATP-binding transporter (1). This is believed to affect
the import and function of very-long-chain acyl-CoA synthetase in per-
oxisomes and not the function of peroxisomal acyl-CoA oxidases or of
other peroxisomal enzymes.
The most widely used therapy consists of a diet free of very-long-chain
fatty acids and supplemented with Lorenzo’s Oil. It reduces very-long-
chain fatty acid levels but amelioration of clinical manifestations is
seldomly observed (2).
Large-scale trials of this dietary therapy are already being conducted
(3–5) while no experimental studies on the effects of Lorenzo’s Oil have
been reported. In literature, data on the effects of oleic acid or erucic acid
containing diets sometimes are conflicting and do not allow to make a
prediction on the effect of Lorenzo’s Oil on peroxisomal metabolism. Our
aim was to investigate light microscopic characteristics of peroxisomes
and the activity of several peroxisomal enzymes in mice fed diets sup-
plemented with Lorenzo’s Oil.
Materials and Methods
Adult male NMRI mice (35–40g) were fed a powdered chow (A04, UAR,
Epinay, France), supplemented with 2 and 10% (w/w) Lorenzo’s Oil
(Scientific Hospital Supplies, Liverpool, U.K.) during 3, 21 and 100 days.
All animals had free access to food and water. The chow contained 3%
(w/w) lipids. Matched control mice only received the standard chow.
The concentrations of Lorenzo’s Oil approximated the daily doses
administered to children with X-linked adrenoleukodystrophy. We con-
sidered the body surface area as reference point to convert doses from
children to mice (6): a dose of 3 g/kg/day (maximum dose found in
literature (3)) given to a child weighing 20 kg corresponds to a daily intake
of 25 g/kg body weight in the mouse. The daily intake of Lorenzo’s Oil by
the mice on a diet with 2% or 10% (w/w) Lorenzo’s Oil was 6.3 and 31.5
g/kg body weight, respectively. An additional experiment using a 20%
Lorenzo’s Oil diet for 3 and 21 days was set up to study the effects of a
“high-fat” diet on the peroxisomes. These animals consumed 63 g Loren-
zo’s Oil/kg body weight/day.
Animals were killed by cervical dislocation after ether anaesthesia. For
histological analysis, cryosections of fixed material (from the middle lobe
of the liver, the myocardial left ventricle wall and the kidney cortex) were
incubated with diaminobenzidine at pH 10.5 (catalase staining of peroxi-
somes) and evaluated by means of a comparative light microscope.
The organs were kept at 280°C before enzyme assays were performed.
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All measurements were performed within the linear range for enzyme
activity as previously described (7). Catalase (EC 1.11.1.6) activity was
measured at 0°C in homogenates of liver, myocardium and kidney cortex
using the titanium oxysulphate method. One U is the amount of catalase
which breaks down 90% of the substrate (1.5 mM H2O2) in a volume of
50 mL at 0°C in 1 min.; maximal reaction time is 10 min. Hepatic
peroxisomal fatty acyl-CoA oxidase (EC 1.3.99.3; the rate limiting en-
zyme for peroxisomal b-oxidation of fatty acids) and L-a-hydroxyacid
oxidase (EC 1.1.3.15; an enzyme not involved in b-oxidation of fatty
acids) were assayed by a fluorometric method.
For the assay of erucic and oleic acid in liver, total lipids were extracted
from 0.5 mL of liver homogenates with chloroform/methanol (2:1) using
the method of Folch et al. (8). Ten mg of nonadecanoic acid (Sigma, St
Louis, USA) was added as internal standard. Fatty acids were transesteri-
fied by incubating 12 h at 80°C with methanol/H2SO4. Fatty acid methyl
esters were separated on a DBI capillary column (J&W Scientific, Rancho
Cordova, USA) on a gas chromatograph (Varian, Walnut Creek, USA).
Quantification of erucic and oleic acids was done with the standard of
nonadecanoic acid.
Each experimental group consisted of five animals. All results are
presented as the mean 6 SEM. For statistical analysis the Kruskal-Wallis
test was used. Significance was obtained when p , 0.05.
This study was approved by the Ethical Committee of the Vrije Uni-
versiteit Brussel and was conform to the ethical guidelines of the Decla-
ration of Helsinki.
Results
Control mice showed no time-dependent differences in weight data,
activities of lauroyl-CoA oxidase, glycolate oxidase or catalase, nor in per-
oxisomal morphology and therefore, were pooled into one control group.
No differences in appetite between groups of animals were observed.
Mean body weight as well as mean weight of liver, heart and kidneys
were not significantly changed in Lorenzo’s Oil-treated animals. No
correlations between the weight data and the duration of feeding or
dietary concentration of Lorenzo’s Oil were found.
The liver of untreated mice contained 0.63 6 0.02 mg erucic acid/mg
protein and 27.28 6 1.03 mg oleic acid/mg protein. A diet containing 2%
Lorenzo’s Oil provoked an 1.3-fold increase in hepatic erucic acid con-
centration when administered for 100 days. In mice fed a diet with 10%
Lorenzo’s Oil for 21 and 100 days, the concentration of erucic acid in the
liver was significantly increased 2.2-fold and 2.6-fold, respectively. Mice
treated with the 20% Lorenzo’s Oil-supplemented diet for 21 days re-
vealed a 2.6-fold increase in hepatic erucic acid level. The ratio erucic
acid/oleic acid did not differ between mice treated with different loren-
zo’s Oil-containing diets.
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Mean hepatic peroxisomal lauroyl-CoA oxidase and glycolate oxidase
activities were unchanged in either group of treated mice (Table 1). No
time-dependent nor dose-dependent changes in fatty acyl-CoA oxidase
and glycolate oxidase activities were observed.
The diet with 2% Lorenzo’s Oil did not affect hepatic catalase activity
(Table 1). Diets containing 10% and 20% Lorenzo’s Oil only provoked a
significant change (i.e., decrease) in hepatic catalase activity after 3 days
of treatment. When all individual enzymatic data were pooled, no signif-
icant linear correlation between the activity of catalase (a H2O2-scaveng-
ing enzyme) on the one hand and the activity of glycolate oxidase and/or
lauroyl-CoA oxidase (two H2O2-producing enzymes) on the other hand
was found.
Myocardial catalase activity was significantly increased in all treated
groups except in mice fed 2% Lorenzo’s Oil for 3 days (Table 1). Renal
catalase activity was unaffected by any dose of Lorenzo’s Oil tested (Table 1).
Light microscopic evaluation revealed no changes in peroxisomal
number, size, distribution or catalase staining in hepatocytes, myocard-
iocytes and epithelial cells of the proximal renal tubules of mice fed the
Lorenzo’s Oil-supplemented diets. No accumulation of lipid droplets was
observed in the liver, myocardium and kidney of any of the treated mice.
Discussion
The increased concentrations of erucic acid measured in liver homoge-
nates of mice fed Lorenzo’s Oil-containing diets for longer periods indi-
TABLE 1. Enzyme activities in mice treated with different dietary concentrations of Lorenzo’s Oil
for up to 100 days
Concentration
and duration
of Lorenzo’s Oil
treatment
Hepatic
lauroyl-CoA
oxidase
activity
(nmol H2O2/
min.mg protein)
Hepatic
glycolate
oxidase
activity
(nmol H2O2/
min.mg protein)
Hepatic
catalase
activity
(mU/mg
protein)
Myocardial
catalase
activity
(mU/mg
protein)
Renal
catalase
activity
(mU/mg
protein)
0% (controls) 2.95 6 0.48 1.31 6 0.23 507 6 63 1.20 6 0.08 33 6 2
2% during 3 days 3.82 6 0.28 2.21 6 0.45 428 6 27 1.17 6 0.07 31 6 2
2% during 21 days 2.60 6 0.10 0.80 6 0.26 478 6 40 1.55 6 0.03a 37 6 3
2% during 100 days 4.19 6 0.46 0.60 6 0.16 505 6 47 1.53 6 0.06a 40 6 5
10% during 3 days 3.54 6 0.62 1.92 6 0.40 360 6 27a 2.03 6 0.04a 36 6 2
10% during 21 days 5.25 6 1.06 2.08 6 0.71 558 6 64 2.12 6 0.08a 33 6 3
10% during 100 days 3.28 6 0.27 0.96 6 0.24 517 6 16 2.26 6 0.10a 36 6 2
20% during 3 days 3.67 6 0.34 1.28 6 0.22 368 6 32a 1.93 6 0.09a 33 6 2
20% during 21 days 4.33 6 0.43 2.14 6 0.47 601 6 17 2.27 6 0.12a 39 6 3
Each experimental group consisted of 5 animals.
Data are significantly different from control data (p , 0.05).
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cate that the diet supplement is absorbed by the intestinal tract of the
mice. Thus the failure to induce changes in hepatic and renal peroxisomal
enzyme activities can not be ascribed to intestinal malabsorption of
Lorenzo’s Oil.
Our data indicate that Lorenzo’s Oil diet has no effect on the activity
of hepatic peroxisomal fatty acyl-CoA oxidase (the H2O2-producing and
rate limiting enzymatic step in peroxisomal fatty acid b-oxidation) in
mice. In literature only reports dealing with high-fat diets containing
important amounts of oleic acid or erucic acid are present. Hepatic fatty
acyl-CoA oxidation was unchanged in rodents fed high-fat diets contain-
ing varying amounts (up to 73.8%) of oleic acid (9). High-rapeseed oil
containing 44% erucic acid had a negative modulating effect on peroxi-
somal b-oxidation enzyme system in rats (10) while 6% erucic acid added
to a 20% soybean oil diet had no effect (11). Subcutaneous (s.c.) injections
of erucic acid decreased the cyanide-insensitive palmitoyl-CoA depen-
dent dehydrogenase activity by 35% in rats (10). The absence of peroxi-
somal b-oxidation induction in mice fed 20% Lorenzo’s Oil indicates that
neither oleic acid nor erucic acid is responsible for the often observed
induction provoked by the more complex natural oils when supple-
mented in high doses.
Lorenzo’s Oil supplemented diets did not alter hepatic glycolate oxi-
dase activity. Only one other hepatic oxidase not involved in fatty acid
oxidation, was previuosly studied in diet experiments: urate oxidase was
unchanged in rats fed high caloric concentrations (30%) of partially
hydrogenated marine oil (12). The pure oil contained 15.1% oleic acid and
14.5% erucic acid (11).
Diets with Lorenzo’s Oil supplementation did not induce hepatic
catalase activity. This is in accordance to the lack of induction of lauroyl-
CoA oxidase and glycolate oxidase and also suggests the absence of
induction of other H2O2-producing metabolic pathways in the liver of
treated mice. The normal peroxisomal morphology is consistent with
these findings. A high-fat diet based on olive oil (which contains 65.6%
oleic acid) decreased catalase activity with 6 23% while a high-fat diet
based on partially hydrogenated peanut oil (which contains 63.6% oleic
acid) had no effect (13). The effect of erucic acid on hepatic catalase
activity has not been investigated.
Lorenzo’s Oil treatment induces myocardial catalase activity. This
was also observed in rats fed 20% partially hydrogenated fish oil 1 5%
soybean oil (14). Since partially hydrogenated fish oil contains about 15%
erucic acid (11), the final dietary concentration approximated 3% which
holds the middle between the erucic acid concentration in 10% and 20%
Lorenzo’s Oil diets. Catalase induction may be linked to a simultaneous
increase in peroxisomal b-oxidation: the diet with 20% partially hydro-
genated fish oil 1 5% soybean oil also induced the cyanide-insensitive
palmitoyl-CoA dependent NAD1-reduction (14). A diet with 18.6% olive
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oil (contained 78.7% oleic acid) did not change antimycin- and rotenone-
insensitive oxidation rates of [1-14C] palmitate in the heart of rats (15). We
therefore assume that the induction of myocardial catalase activity in mice
treated with Lorenzo’s Oil is due to the presence of erucic acid in the diet.
The increases in myocardial catalase activity were not reflected in an
enhanced staining intensity of the individual peroxisomes. Apparently,
the intensity of the oxidized diaminobenzidine in sections cytochemi-
cally stained for catalase is little susceptible to the observed changes in
activity of this enzyme.
The well-known myocardial lipidosis provoked by erucic acid-contain-
ing diets (16) was absent in mice treated with Lorenzo’s Oil. This may be
explained by the transient nature of this phenomenon: the rapid increase
in catalase activity (already after 3 days with the highest 2 Lorenzo’s oil
concentrations) indicates a fast adaptation of the myocardial metabolism.
We found no renal peroxisomal changes. No data on effects of oleic
acid and erucic acid containing diets on renal peroxisomes are available.
Our data demonstrate that in the liver of normal mice, Lorenzo’s Oil
does not induce lauroyl-CoA oxidase and catalase. This contrasts with
the effects of peroxisome proliferators and high doses of certain complex
vegetable and animal oils (7,17). This difference together with the ab-
sence of visual lipid accumulation in the liver of mice fed the Lorenzo’s
Oil-supplemented diets may indirectly suggest that the hepatic peroxi-
somal b-oxidation capacity in treated mice was not overloaded by the
excess of erucic and oleic acids.
X-linked adrenoleukodystrophy patients have a defective capacity to
b-oxidize very-long-chain fatty acids due to a defiency of very-long-chain
fatty acyl-CoA synthetase (18). However peroxisomal b-oxidation of eru-
cic acid is not impaired in skin fibroblasts from these patients (19). There-
fore, no accumulation of both monoenoic fatty acids present in Lorenzo’s Oil
is expected in liver of X-linked adrenoleukodystrophy patients and an over-
load of the peroxisomal b-oxidation capacity is unlikely.
The mechanism of the effect of Lorenzo’s Oil in serum of X-linked
adrenoleukodystrophy patients (i.e., the normalization of the level of
very-long-chain fatty acids) may not be a direct effect on the peroxisomes.
The long monoenoic fatty acids of the oil are believed to compete with
and thus reduce the elongation of saturated fatty acids to very-long-chain
fatty acids in the endoplasmic reticulum (20,21).
At present there is no evidence of clinically relevant benefit of Loren-
zo’s Oil-treatment in symptomatic X-linked adrenoleukodystrophy pa-
tients; a preventative effect of this treatment is currently under investi-
gation (22,23). Side-effects of dietary Lorenzo’s Oil are lower platelet
counts (24) and bleeding diathesis due to decreased platelet membrane
anisotropy (25).
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